Adjuvant Immunotherapy for Liver Transplant Recipients with Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells

被引：0
|
作者：
Ohira, M. [1 ]
Hotta, R. [1 ]
Imaoka, Y. [1 ]
Sato, K. [1 ]
Tanimine, N. [1 ]
Tahara, H. [1 ]
Ide, K. [1 ]
Kobayashi, T. [1 ]
Tanaka, Y. [1 ]
Tzakis, A. [2 ]
Nishida, S. [2 ]
Ohdan, H. [1 ]
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Univ Miami, Miami, FL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
251
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [31] Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
    Kamiya, Takahiro
    Chang, Yu-Hsiang
    Campana, Dario
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (07) : 574 - 581
  • [32] Adoptive Immunotherapy With Deceased Donor Derived-Liver Natural Killer (NK) Cells Is Well Tolerated and Has the Potential to Become a Powerful Therapeutic Tool for Preventing Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
    Hotta, R.
    Nishida, S.
    Muraoka, I.
    Ohira, M.
    Ohdan, H.
    Vianna, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 167 - 167
  • [33] Recurrent hepatocellular carcinoma in liver transplant recipients with hepatitis C
    Zendejas-Ruiz I.
    Hemming A.W.
    Chen C.
    Schwartz J.J.
    Sorensen J.B.
    Kim R.D.
    Journal of Gastrointestinal Cancer, 2012, 43 (2) : 229 - 235
  • [34] Recurrent hepatocellular carcinoma in liver transplant recipients with hepatitis C
    Zendejas, Ivan
    Mizuno, Shugo
    Fujita, Shiro
    Kayler, Liise K.
    Magliocca, Joseph F.
    Reed, Alan I.
    Firpi, Roberto
    Cabrera, Ron
    Soldevila-Pico, Consuelo
    Nelson, David
    Hemming, Alan W.
    Kim, Robin D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 382 - 382
  • [35] Phase I study of adjuvant immunotherapy using donor liver derived NK cells for preventing HCC recurrence after liver transplantation
    Imaoka, Y.
    Sato, K.
    Imaoka, K.
    Tanimine, N.
    Tahara, H.
    Ide, K.
    Kobayashi, T.
    Tanaka, Y.
    Tzakis, A.
    Nishida, S.
    Ohdan, H.
    Ohira, M.
    TRANSPLANTATION, 2022, 106 (8S) : 61 - 61
  • [36] Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
    Hussaarts, Koen G. A. M.
    van Doorn, Leni
    Bins, Sander
    Sprengers, Dave
    de Bruijn, Peter
    van Leeuwen, Roelof W. F.
    Koolen, Stijn L. W.
    van Gelder, Teun
    Mathijssen, Ron H. J.
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 10
  • [37] Comparison of Locoregional Therapies for Hepatocellular Carcinoma in Liver Transplant Recipients
    Chen, M.
    Philosophe, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 436 - 436
  • [38] RECURRENT HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C
    Zendejas, Ivan
    Mizuno, Shugo
    Hemming, Alan W.
    Kim, Robin D.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S253 - S253
  • [39] Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma
    Woo, Stephanie M.
    Kimchy, Alexandra V.
    Sequeira, Lynette M.
    Dorris, Charles S.
    He, Aiwu R.
    Rangnekar, Amol S.
    CURRENT ONCOLOGY, 2022, 29 (12) : 9813 - 9825
  • [40] Changes in natural killer cell subsets in pediatric liver transplant recipients
    Pham, Betty
    Piard-Ruster, Karine
    Silva, Richard
    Gallo, Amy
    Esquivel, Carlos O.
    Martinez, Olivia M.
    Krams, Sheri M.
    PEDIATRIC TRANSPLANTATION, 2012, 16 (02) : 176 - 182
12345